We observed an association of variants associated with higher fasting insulin with higher risk of endometrial cancer (odds ratio [OR] per genetically predicted SD of log-FI = 2.34, 95% confidence interval [CI] = 1.06 to 5.14, P = .03) (Table 1). The gene discussed is INS; the disease is endometrial cancer.